title: Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine.
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
authors.forename: Julie C
authors.initials: JC
authors.lastname: Porcher
authors.forename: Mark R
authors.initials: MR
authors.lastname: Litzow
authors.forename: William J
authors.initials: WJ
authors.lastname: Hogan
authors.forename: Sujata
authors.initials: S
authors.lastname: Arora
authors.forename: Emily S
authors.initials: ES
authors.lastname: Van Laar
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D050677:Core Binding Factor Alpha 3 Subunit / Q000235:genetics; D020732:Cytogenetic Analysis; D004265:DNA Helicases / Q000235:genetics*; D000077209:Decitabine; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D009687:Nuclear Proteins / Q000235:genetics*; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D000075924:X-linked Nuclear Protein
chemical_list: D000964:Antimetabolites, Antineoplastic; D050677:Core Binding Factor Alpha 3 Subunit; D009687:Nuclear Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; C493729:Runx3 protein, human; D000077209:Decitabine; D004265:DNA Helicases; C092332:ATRX protein, human; D000075924:X-linked Nuclear Protein; D001374:Azacitidine